Tag results:

cell transplantation

Use of CAR T Cell for Acute Lymphoblastic Leukemia (ALL) Treatment: A Review Study

[Cancer Gene Therapy] Scientists discuss different generations, challenges, and clinical studies related to chimeric antigen receptor (CAR) T cells for ALL treatment.

Research Progress of the Application of Mesenchymal Stem Cells in Chronic Inflammatory Systemic Diseases

[Stem Cell Research & Therapy] The authors describe the research progress and clinical application of MSCs in chronic inflammatory systemic diseases and look for influencing factors and biomarkers that can predict the outcome of patient with mesenchymal stem cell transplantation.

Comparable Anti-CMV Responses of Transplant Donor and Third-Party CMV-Specific T Cells for Treatment of CMV Infection after Allogeneic Stem Cell Transplantation

[Cellular & Molecular Immunology] The in vivo recovery of cytomegalovirus (CMV)-specific immunity after CMV-cytotoxic T lymphocytes (CTL) infusion was comparable in two groups. A detailed analysis of the source of recovered CMV-CTLs showed the proliferation and expansion of graft-derived endogenous CMV-CTLs in both groups.

Naive T Cell Depletion to Prevent Chronic Graft-Versus-Host Disease

[Journal of Clinical Oncology] 138 patients with acute leukemia received Naive T cell-depleted peripheral blood stem-cell from HLA-matched related or unrelated donors following conditioning with high- or intermediate-dose total-body irradiation and chemotherapy.

HLA 1–3 Antigen-Mismatched Related Peripheral Blood Stem Cells Transplantation Using Low-Dose Antithymocyte Globulin versus Unrelated Cord Blood Transplantation

[American Journal of Hematology] Researchers evaluated 7861 patients with hematologic malignancies who received either a cord blood transplantr without anti-thymocyte globulin (ATG) or an HLA 1-3 antigen–mismatched related donor peripheral blood stem-cell transplantation using low-dose ATG.

Researchers Awarded Grant to Study New Method of Islet Transplantation

[Weill Cornell Medicine] Weill Cornell Medicine researchers have received a two-year $500,000 grant from JDRF to evaluate an innovative approach to islet cell transplantation, an experimental treatment for difficult-to-control type 1 diabetes.

Popular